These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 28679021)

  • 1. Population Pharmacokinetic Analysis of Vaginally and Intravenously Administered Oxytocin in Postmenopausal Women.
    Nielsen EI; Al-Saqi SH; Jonasson AF; Uvnäs-Moberg K
    J Clin Pharmacol; 2017 Dec; 57(12):1573-1581. PubMed ID: 28679021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxytocin improves cytological and histological profiles of vaginal atrophy in postmenopausal women.
    Al-Saqi SH; Jonasson AF; Naessén T; Uvnäs-Moberg K
    Post Reprod Health; 2016 Mar; 22(1):25-33. PubMed ID: 26883689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravaginally applied oxytocin improves post-menopausal vaginal atrophy.
    Al-Saqi SH; Uvnäs-Moberg K; Jonasson AF
    Post Reprod Health; 2015 Sep; 21(3):88-97. PubMed ID: 25995333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical oxytocin reverses vaginal atrophy in postmenopausal women: a double-blind randomized pilot study.
    Jonasson AF; Edwall L; Uvnäs-Moberg K
    Menopause Int; 2011 Dec; 17(4):120-5. PubMed ID: 22120944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of topical oxytocin in improving vaginal atrophy in postmenopausal women: a randomized, controlled trial.
    Torky HA; Taha A; Marie H; El-Desouky E; Raslan O; Moussa AA; Ahmad AM; Abo-Louz A; Zaki S; Fares T; Eesa A
    Climacteric; 2018 Apr; 21(2):174-178. PubMed ID: 29347848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability and pharmacokinetics of sublingual oxytocin in male volunteers.
    De Groot AN; Vree TB; Hekster YA; Pesman GJ; Sweep FC; Van Dongen PJ; Van Roosmalen J
    J Pharm Pharmacol; 1995 Jul; 47(7):571-5. PubMed ID: 8568623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Misoprostol and oxytocin in induction of labour in women with prolonged pregnancy--safety and effectiveness comparison].
    Wilk M; Jureczko T; Poreba R; Sipiński A
    Wiad Lek; 2001; 54(11-12):662-7. PubMed ID: 11928554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EFFECTIVENESS AND SAFETY OF 2-HOURLY 20 MCG ORAL MISOPROSTOL SOLUTION COMPARED TO STANDARD INTRAVENOUS OXYTOCIN IN LABOUR INDUCTION DUE TO PRE-LABOUR RUPTURE OF MEMBRANES AT TERM: A RANDOMISED CLINICAL TRIAL AT KENYATTA NATIONAL HOSPITAL.
    Mbaluka CM; Kamau K; Karanja JG; Mugo N
    East Afr Med J; 2014 Sep; 91(9):303-10. PubMed ID: 26866082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suitability of low-dosage oxytocin treatment to induce milk ejection in dairy cows.
    Belo CJ; Bruckmaier RM
    J Dairy Sci; 2010 Jan; 93(1):63-9. PubMed ID: 20059905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetic modelling of Emfilermin (recombinant human leukaemia inhibitory factor, r-hLIF) in healthy postmenopausal women and in infertile patients undergoing in vitro fertilization and embryo transfer.
    Goggin T; Nguyen QT; Munafo A
    Br J Clin Pharmacol; 2004 May; 57(5):576-85. PubMed ID: 15089810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial.
    Borruto F; Treisser A; Comparetto C
    Arch Gynecol Obstet; 2009 Nov; 280(5):707-12. PubMed ID: 19229549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of uterine activity. Using oxytocin after intracervical PGE2.
    Coleman FH; Rayburn WF; Burks LS; Farmer KC; Larson JD; Turnbull GL
    J Reprod Med; 1997 Jan; 42(1):44-8. PubMed ID: 9018645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the bioavailability and pharmacokinetics of oral methylergometrine in men and women.
    de Groot AN; Vree TB; Hekster YA; van den Biggelaar-Martea M; van Dongen PW; van Roosmalen J
    Int J Clin Pharmacol Ther; 1995 Jun; 33(6):328-32. PubMed ID: 7582383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving patient safety and uniformity of care by a standardized regimen for the use of oxytocin.
    Hayes EJ; Weinstein L
    Am J Obstet Gynecol; 2008 Jun; 198(6):622.e1-7. PubMed ID: 18355786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.
    Ramsey PS; Savage K; Lincoln T; Owen J
    Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose vaginal misoprostol versus concentrated oxytocin plus low-dose vaginal misoprostol for midtrimester labor induction: a randomized trial.
    Nuthalapaty FS; Ramsey PS; Biggio JR; Owen J
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1065-70. PubMed ID: 16157113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal Dinoprostone Versus Intravenous Oxytocin for Labor Induction in Patients Not Responsive to a First Dose of Dinoprostone: A Randomized Prospective Study.
    Antonazzo P; Laoreti A; Personeni C; Grossi E; Martinelli A; Cetin I
    Reprod Sci; 2016 Jun; 23(6):779-84. PubMed ID: 26626794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and preliminary efficacy of two vaginal gel formulations of ultra-low-dose estriol in postmenopausal women.
    Delgado JL; Estevez J; Radicioni M; Loprete L; Moscoso Del Prado J; Nieto Magro C
    Climacteric; 2016 Apr; 19(2):172-80. PubMed ID: 26786399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two preparations of dinoprostone for pre-induction of labour in nulliparous women with very unfavourable cervical condition: a randomised clinical trial.
    Facchinetti F; Venturini P; Verocchi G; Volpe A
    Eur J Obstet Gynecol Reprod Biol; 2005 Apr; 119(2):189-93. PubMed ID: 15808378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo influence of carbetocin on equine myometrial muscles and comparison with oxytocin.
    Steckler D; Naidoo V; Gerber D; Kähn W
    Theriogenology; 2012 Aug; 78(3):502-9. PubMed ID: 22538009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.